List of insiders holdings for Nuwellis Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Harvey Mark Director | 2012-05-10 16:56:22 | 11,685 1,878,248 | 1,889,933 | Form 3/A |
CM Capital CM Capital Venture 4A A/C CM Capital Venture 4B A/C 10% Owner | 2012-05-10 16:56:44 | 0 1,877,498 | 1,877,498 | Form 3/A |
Choi Ki Yong 10% Owner | 2017-10-13 20:06:20 | 1,793,109 0 | 1,793,109 | Form 4 |
Brooke Geoffrey Director | 2014-06-02 14:15:23 | 10,621 1,194,761 | 1,205,382 | Form 4 |
Talu Ventures Pty Ltd CM Capital Venture 4B A/C CM Capital Venture 4A A/C 10% Owner | 2017-01-18 19:26:59 | 634,817 0 | 634,817 | Form 13G |
Breidenstein Jim Chief Commercial Officer | 2018-01-05 16:12:47 | 181,068 0 | 181,068 | Form 4 |
Verta Patrick Chief Medical Officer | 2013-10-23 08:52:24 | 148,000 0 | 148,000 | Form 4 |
Rosa David A Chief Executive Officer | 2015-08-03 16:33:28 | 119,587 0 | 119,587 | Form 4 |
Lovett Eric VP, Clinical Affairs | 2016-01-15 16:28:07 | 104,000 0 | 104,000 | Form 4 |
BUCKMAN PAUL Director | 2016-05-31 16:18:58 | 79,508 0 | 79,508 | Form 4 |
O'Dwyer Donal Director | 2012-08-23 17:15:39 | 686 62,836 | 63,522 | Form 4/A |
Peters William S CTO & Medical Director Director | 2015-01-02 16:47:20 | 33,309 18,757 | 52,066 | Form 4 |
MATHIESEN JEFFREY S Chief Financial Officer | 2015-01-02 16:29:55 | 37,223 11,875 | 49,098 | Form 4 |
Montague George CFO and Treasurer | 2022-03-04 13:09:16 | 40,054 0 | 40,054 | Form 4 |
Callinan Nicholas Director | 2012-09-18 15:55:37 | 0 32,147 | 32,147 | Form 4 |
Kridner Debra Exec VP, Regulatory Affairs | 2015-08-11 14:48:53 | 29,500 0 | 29,500 | Form 4 |
McCormick Michael Kendrick Director | 2024-01-04 16:25:39 | 20,836 0 | 20,836 | Form 4 |
Brown Brian SVP, Technology & Operations | 2015-08-14 11:33:44 | 20,000 0 | 20,000 | Form 4 |
Scott Robert Benjamin Chief Financial Officer | 2023-09-06 16:23:45 | 18,643 0 | 18,643 | Form 4 |
Brandt Steven Frank Director | 2022-05-26 16:08:23 | 15,806 0 | 15,806 | Form 4 |
Blake Lynn Larson Chief Financial Officer | 2023-01-09 16:37:42 | 12,417 0 | 12,417 | Form 4 |
McDonald David Director | 2024-01-04 16:21:51 | 11,365 0 | 11,365 | Form 4 |
Feldshon Archelle Georgiou Director | 2024-01-04 16:16:08 | 11,365 0 | 11,365 | Form 4 |
Drayton Claudia Chief Financial Officer | 2021-01-26 20:58:42 | 10,500 0 | 10,500 | Form 4 |
Bassett Kevin Senior VP, Tech & Operations | 2014-05-09 16:20:27 | 10,426 0 | 10,426 | Form 4 |
Yearick Jim VP of Marketing and Sales | 2014-05-09 16:55:30 | 10,153 0 | 10,153 | Form 4 |
AYOTTE NEIL P SVP, Secretary, GC & CCO | 2023-03-07 17:14:06 | 8,640 0 | 8,640 | Form 4 |
Lynch Thomas P. Chief Legal Compliance Officer | 2021-01-26 21:22:39 | 7,000 0 | 7,000 | Form 4 |
Jaramillo Nestor Jr. President and CEO | 2023-03-16 17:11:18 | 4,098 0 | 4,098 | Form 4 |
Oleson Kimberly SVP, Clinical Affairs | 2015-06-03 16:33:07 | 3,810 0 | 3,810 | Form 4 |
ERB JOHN L Director | 2023-05-23 16:10:52 | 2,146 0 | 2,146 | Form 4 |
WATSON WARREN S Director | 2023-05-23 16:12:00 | 2,146 0 | 2,146 | Form 4 |
WALLER GREGORY D Director | 2023-05-23 16:18:04 | 2,146 0 | 2,146 | Form 4 |
Salveson Jon W Director | 2023-05-23 16:23:59 | 2,146 0 | 2,146 | Form 4 |
Likens Matthew E. Director | 2019-05-28 16:37:08 | 1,970 0 | 1,970 | Form 4 |
Wotta Paul Principal Accounting Officer | 2021-04-16 11:12:05 | 1,321 0 | 1,321 | Form 3 |
Costanzo Maria Rosa Director | 2020-01-08 15:03:32 | 1,313 0 | 1,313 | Form 4/A |
Wade Molly Vice President | 2017-01-17 16:23:44 | 909 0 | 909 | Form 4 |
STRAUS ASSET MANAGEMENT LLC STRAUS MELVILLE 10% Owner | 2014-02-11 15:29:33 | 0 0 | 0 | Form 13G |
GBS Venture Partners Pty Ltd GBS Bioventures II A/C GBS Bioventures III A/C 10% Owner | 2017-02-07 17:04:49 | 0 0 | 0 | Form 13G |